130 related articles for article (PubMed ID: 15653119)
1. An index of community ocular Chlamydia trachomatis load for control of trachoma.
Alexander ND; Solomon AW; Holland MJ; Bailey RL; West SK; Shao JF; Mabey DC; Foster A
Trans R Soc Trop Med Hyg; 2005 Mar; 99(3):175-7. PubMed ID: 15653119
[TBL] [Abstract][Full Text] [Related]
2. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
[TBL] [Abstract][Full Text] [Related]
3. Is there evidence for resistance of ocular Chlamydia trachomatis to azithromycin after mass treatment for trachoma control?
West SK; Moncada J; Munoz B; Mkocha H; Storey P; Hardick J; Gaydos CA; Quinn TC; Schachter J
J Infect Dis; 2014 Jul; 210(1):65-71. PubMed ID: 24446528
[TBL] [Abstract][Full Text] [Related]
4. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
[TBL] [Abstract][Full Text] [Related]
5. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
[TBL] [Abstract][Full Text] [Related]
6. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
Last AR; Burr SE; Harding-Esch E; Cassama E; Nabicassa M; Roberts CH; Mabey DCW; Holland MJ; Bailey RL
Parasit Vectors; 2017 Dec; 10(1):624. PubMed ID: 29282126
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
Cajas-Monson LC; Mkocha H; Muñoz B; Quinn TC; Gaydos CA; West SK
PLoS Negl Trop Dis; 2011 Mar; 5(3):e978. PubMed ID: 21423645
[TBL] [Abstract][Full Text] [Related]
8. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
Harding-Esch EM; Holland MJ; Schémann JF; Sillah A; Sarr B; Christerson L; Pickering H; Molina-Gonzalez S; Sarr I; Andreasen AA; Jeffries D; Grundy C; Mabey DCW; Herrmann B; Bailey RL
Parasit Vectors; 2019 Oct; 12(1):497. PubMed ID: 31640755
[TBL] [Abstract][Full Text] [Related]
9. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
Campbell JP; Mkocha H; Munoz B; West SK
Ophthalmic Epidemiol; 2012 Feb; 19(1):38-42. PubMed ID: 22273357
[TBL] [Abstract][Full Text] [Related]
10. Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment.
Gower EW; Solomon AW; Burton MJ; Aguirre A; Muñoz B; Bailey R; Holland M; Makalo P; Massae P; Mkocha H; Mabey DC; West SK
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4767-71. PubMed ID: 17065486
[TBL] [Abstract][Full Text] [Related]
11. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
[TBL] [Abstract][Full Text] [Related]
12. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
Ramadhani AM; Derrick T; Macleod D; Massae P; Malisa A; Mbuya K; Mtuy T; Makupa W; Roberts CH; Bailey RL; Mabey DCW; Holland MJ; Burton MJ
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007559. PubMed ID: 31306419
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of high dose azithromycin compared to standard dosing for children with severe trachoma in Tanzania.
Campbell JP; Mkocha H; Munoz B; West SK
Ophthalmic Epidemiol; 2009; 16(3):175-80. PubMed ID: 19437312
[TBL] [Abstract][Full Text] [Related]
14. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
[TBL] [Abstract][Full Text] [Related]
15. Mass treatment with single-dose azithromycin for trachoma.
Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
[TBL] [Abstract][Full Text] [Related]
17. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
Wolle MA; Muñoz BE; Mkocha H; West SK
Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
[TBL] [Abstract][Full Text] [Related]
19. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme.
Mkocha H; Munoz B; West S
Tanzan J Health Res; 2009 Jul; 11(3):103-10. PubMed ID: 20734706
[TBL] [Abstract][Full Text] [Related]
20. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
